Results 91 to 100 of about 447,838 (312)
Drug Delivery, 2017 Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-based combination therapy and gene therapy are new strategies to potentially overcome the limitations of TRAIL, however, the lack of efficient and low toxic vectors remains the major ...
Shengpeng Wang +7 more
doaj +1 more source
A DR4, DR5 Targeting Conjugated TRAIL Treatment for Colorectal Carcinogenesis: A Way to Future? [PDF]
Pharmaceutical SciencesTRAIL or tumor necrosis factor-related apoptosis-inducing ligand has been one of the major frontiers for the chemotherapeutic approach to treating carcinogenesis.
Parikshit Roychowdhury +7 more
doaj +1 more source
The NO TRAIL to YES TRAIL in cancer therapy (Review)
International Journal of Oncology, 2007 Treatment of cancer patients with conventional therapies (chemotherapy, hormonal therapy, immunotherapy and radiation) respond initially well and experience prolonged tumor-free survival. However, in many patients tumor recurrences and relapses occur and such tumors exhibit the resistant phenotype i.e.
Ji Yeun, Lee +5 more
openaire +3 more sources
Recreational Demand for Equestrian Trail-Riding [PDF]
Using data collected from a combination of on-site and on-line surveys, this study examines recreational demand for equestrian trail-riding in Kentucky.
Blackwell, Melanie +3 more
core
Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer
Molecular Oncology, EarlyView.Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas +16 more
wiley +1 more source
Combining an improvement to PARMA trailing with trailing analysis
Proceedings of the 4th ACM SIGPLAN international conference on Principles and practice of declarative programming, 2002 Trailing of bindings in the PARMA variable representation is expensive in time and space. Two schemes are presented that lower its cost: the first is a technique that halves the space cost of trailing in PARMA. It can be used with conditional and unconditional trailing.
Schrijvers, Tom, Demoen, Bart
openaire +4 more sources
Molecular Oncology, EarlyView.Tumour heterogeneity and clonal evolution of metastatic salivary gland cancer were evaluated in two patients with adenoid carcinoma and one patient with myoepithelial carcinoma. Radiology‐guided autopsy enabled multi‐region sampling (total samples n = 149), followed by whole‐genome sequencing and phylogenetic reconstruction (17 tumour samples, 4–7 per ...
Gerben Lassche +10 more
wiley +1 more source
DESIGN OF MOTORCYLE ACTIVE CHASSIS GEOMETRY CHANGE SYSTEM
Perner’s Contacts, 2011 Modern motorcycles have a number of electronic systems supporting their driving stability. These are usually adopted solutions used in automobiles.
Jakub Šmiraus, Michal Richtář
doaj
Molecular Oncology, EarlyView.This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi +6 more
wiley +1 more source
Research on issues in the protection of clinical trial human subjects in China: a Delphi study
BMC Medical EthicsBackground This study aims to identify current deficiencies in the protection of human subjects participating in clinical trials in China and propose strategies for safeguarding their rights.
Xiuqiao Yang +9 more
doaj +1 more source